SGLT2 Inhibitors for Horses With Metabolic Problems
SGLT2 inhibitors are a newer class of drugs veterinarians are exploring to help manage insulin dysregulation in horses at risk of metabolic laminitis. These medications work by increasing glucose loss through the urine, which can lower blood glucose and reduce insulin levels in horses that don’t respond well to diet and exercise alone. In this Ask TheHorse Live excerpt, Caitrin Lowndes, DVM, Dipl. ABVP, fellow at the University of Pennsylvania’s New Bolton Center, in Kennett Square, answers a listener question about how veterinarians use SLGT2 inhibitors when treating horses with metabolic problems.
This podcast is an excerpt of our Ask TheHorse Live Q&A, “Managing Horses With Metabolic Problems.” Listen to the full recording here.
About the Expert:
Caitrin Lowndes, DVM
Caitrin Lowndes, DVM, is a research fellow at the Van Eps Laminitis and Endocrinology Laboratory at the University of Pennsylvania’s New Bolton Center, in Kennett Square, with a background in field practice. Her main area of research is the improved diagnosis and management of insulin dysregulation, with particular interest in how that research can be translated into clinical practice for the treatment and prevention of laminitis.
Related Articles
Stay on top of the most recent Horse Health news with
